Ways to Give
The Department of Medicine is divided into 11 divisions, any of which you may designate as the recipient of your gift. You may also designate funds for general departmental research through the Center for Translational Medicine. For more information, please contact Margaret Fala at (215) 955-7556, or Margaret.Fala@jefferson.edu
Center for Translational Medicine
Developed in 2003 as the cornerstone of the basic research program within the department, the Center comprises two floors of labs for multidisciplinary and cutting-edge research that is the launching point for the translation of basic findings to patient care. Core facilities include: Genomics, Gene Transfer, Molecular Imaging, Animal Models of Human Disease and Cardiac Physiology, and Stem Cell Biology.
Divisions of Medicine
The Jefferson Heart Institute (JHI) has become a nationally recognized center of excellence in the many aspects of cardiovascular disease. The division also encompasses the Center for Advanced Heart Failure and Cardiac Transplantation, an electrophysiology suite, and outpatient nuclear imaging facilities.
- Pulmonary, Critical Care, Allergic, and Immunologic Diseases
The Division builds on the highest level of care for patients with lung disease. A medical sleep program, in collaboration with the Department of Psychiatry, treats patients with severe cardiac, gastrointestinal, or pulmonary disease who have obstructive sleep apnea. Outpatient clinics include the Asthma Clinic and the Smoking Cessation Clinic.
- Endocrinology, Diabetes, and Metabolic Diseases
With a primary focus on diabetes, obesity, and related disorders, the Division cares for patients with endocrine diseases and also supports a Comprehensive Weight Management Program and a Diabetes Prevention Program.
- Gastroenterology and Hepatology
The Division is recognized nationally as a leader in care for patients with gastrointestinal disease. Faculty has led design and evaluation of related technology for new therapeutic options, including capsule endoscopy. The Inflammatory Bowel Disease (IBD) Diagnostic and Treatment Center oversees treatment of some 2,100 patients at Jefferson with ulcerative colitis and Crohn’s disease.
The Division provides research and patient care related to bleeding and clotting, anemia, and other red cell disorders. The Cardeza Hemophilia Treatment Center is a model for care for more than 200 patients with inherited bleeding and clotting disorders. Active with the Adult and Pediatric/Adolescent Sickle Cell Centers, the Division also cares for the large number of infants and families in Philadelphia’s Chinatown district with Thalassemia syndromes.
- Infectious Diseases & Environmental Medicine
Bringing the latest technological breakthroughs in HIV/AIDS therapy to Jefferson patients, the Division also participates in clinical trials of new therapeutic agents and researches the unique effects of the disease on women. The Center for Human Virology researches viral transmission and vaccine design, and the Center for Biodefense focuses on the pathobiology of biotoxins such as botulinum, pox viruses, and anthrax.
- Internal Medicine
The Division provides primary as well as specialized clinical care to patients with acute and chronic problems, with a strong emphasis on preventive care and counseling education. The Hospitalist Service makes available to patients a team of specially designated physicians throughout their stay at the hospital. Faculty also leads the Vascular Center, which offers a multidisciplinary approach to the diagnosis, management, and treatment of vascular diseases and thrombotic disorders.
The Renal Division includes and active renal transplant program and centers focusing on the outpatient treatment of Chronic Kidney Disease, Diabetic Kidney Disease, and Early Renal Insufficiency. Traditional dialysis programs accompany state-of-the-art clinical research on hypertension and related disorders.
Patients from around the globe seek out physicians from the Division for care in rheumatic diseases, including osteoporosis, scleroderma, lupus, and rheumatoid arthritis. Basic science and clinical research studies seek effective drug therapies as well as breakthroughs in molecular biology and genetic mechanisms.